er in patients with CTD-APAH compared with patients with IPAH. It is possible that a proportion of these deaths and hospitalizations were related to flares or complications of their underlying CTD, such as coronary artery disease, infections, cancer, or other complications related to immunosuppression, rather than PAH. Unlike the recent UK study by Condliffe et al,12 we found that short-term survi